Rheumatologische Schwerpunktpraxis Rendsburg

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Ankylosing spondylitis1 trial
• Sjögren's disease1 trial

Phase

• Phase 31 trial
• Phase 41 trial

Status

• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Novartis Pharmaceuticals2 trials

Running trials

• Recruiting

  Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

  NCT07621809· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  A Study of Secukinumab to Evaluate Maintenance of Response in Participants With Non-radiographic Axial Spondyloarthritis Who Achieved Remission

  NCT05622708· Phase 4· Novartis Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Sjögren's disease1 recruiting